Navigation Links
Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
Date:9/4/2007

amsulosin 0.4 mg/day (n=1519).

ABOUT AVODART

AVODART, the first and only dual 5ARI for the treatment of enlarged prostate, inhibits both the type I and type II isoenzymes responsible for the conversion of testosterone into dihydrotestosterone (DHT). DHT is the primary male hormone responsible for the enlargement of the prostate. AVODART provides the power to suppress DHT by 93 percent at 2 years. Over time, AVODART reduces prostate volume, improves symptoms and arrests the enlarged prostate disease process.

AVODART is indicated for the treatment of symptomatic enlarged prostate in men with an enlarged prostate to improve urinary symptoms, reduce the risk of AUR, and reduce the risk of enlarged prostate-related surgery. While some men have fewer problems and symptoms after three months of treatment with AVODART, a treatment period of at least six months is usually necessary to see if AVODART will improve symptoms.

Only a doctor can tell if symptoms are from an enlarged prostate and not a more serious condition such as prostate cancer. Men should see their doctors for regular exams. Women and children should not take AVODART. Women who are, or could become pregnant should not handle AVODART due to the potential risk of a specific birth defect. Men treated with AVODART should not donate blood until at least six months after their final dose.

Caution should be used in patients with liver disease. Possible side effects include sexual side effects and breast tenderness and/or swelling. These side effects occur infrequently.

For full prescribing information, see http://www.avodart.com.

About Enlarged Prostate

Enlarged prostate is a prevalent and progressive condition that affects 50 percent of men over 50 years of age and over 90 percent of men older than age 80. An enlarged prostate causes changes in urinary habits because of its location around the urethra. Over time, the p
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...alif.,Nov.23/PRNewswire-FirstCall/--DURECTCorporat...fFinancialOfficer,andJoeStauffer,ChiefMedicalOffic...thCareConferenceonTuesday,December1at3:30pmEastern...elinNewYorkCity. ,, (Logo: http://www.newscom.c...thelivepresentationviatheinternet,pleasegotothedir...
(Date:11/23/2009)...S,Calif.,Nov.23/PRNewswire-FirstCall/--Amgen(Nasda...orBestOverallPipelineandforBestNewDrugforNplate...TheBestOverallPipelineawardwaspresentedtoAmgenbySc...potentialofthecompany,spipeline,aswellasitsmixofca...es,Amgen,spipelineisnotableforitsfocusonunmetclini...
(Date:11/23/2009)....23/PRNewswire/--Reportlinker.comannouncesthatanew..., TheFutureoftheDiagnosticImagingMarketto2015 ,...ture-of-the-Diagnostic-Imaging-Market-to-2015.html...ampaign=prnewswire ,, Description ,, T...Summary ,, GlobalMarketsDirect,s"TheFutureofth...
Breaking Medicine Technology:DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11Rodman Renshaw Annual Global Investment Conference in New York on September 10 2009 54846 1Rodman Renshaw Annual Global Investment Conference in New York on September 10 2009 54846 2Rodman Renshaw Annual Global Investment Conference in New York on September 10 2009 54846 3American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device 13627 1American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device 13627 2American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device 13627 3Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta Celebrates 2450 Million of Goodwill 54837 1Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta Celebrates 2450 Million of Goodwill 54837 2Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta Celebrates 2450 Million of Goodwill 54837 3
...rogen therapy available by prescription "seems not...), or blood clotting, in postmenopausal patients...sts. The study was conducted by researchers at NY...latest issue of Menopause: The Journal of the No... transdermal estrogen therapy is bioidentical to e...
...ng is Not Superior to Delayed Provisional Use in P...udy Finds , , KENILWORTH, N.J., March 30 In a s... Sessions of the American College of Cardiology an...nal of Medicine, researchers reported that a strat...EGRILIN(R) (eptifibatide) routinely in patients wi...
Other Medicine Technology:New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery 2New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery 3Schering-Plough Announces Results of the Early ACS Trial 2Schering-Plough Announces Results of the Early ACS Trial 3Schering-Plough Announces Results of the Early ACS Trial 4Schering-Plough Announces Results of the Early ACS Trial 5Schering-Plough Announces Results of the Early ACS Trial 6
(Date:11/23/2009)...uarters of cancer patients and survivors treated w...s that often become chronic conditions, hindering ...cientists at the University of Rochester Medical C...hey experienced sleep troubles at nearly three tim... was more prevalent in younger patients and those ...
(Date:11/23/2009)...erybody, health care professionals enjoy a pay rai...ancial incentives for health care performance may ...hat patient-care performance ratings for 25 medica...following the launch of a statewide pay-for-perfor...used on doctors, productivity. , Reporting in...
(Date:11/23/2009)...es saw their odds drop by 63 percent with moderate...Nov. 23 (HealthDay News) -- Moderate-to-high inten...may help reduce stroke risk in older men but not i...ed almost 3,300 men and women, average age 69, in ...During that time, there were 238 strokes among the...
(Date:11/23/2009)...ips doubled number of patients who reined in their... Nov. 23 (HealthDay News) -- High blood pressure i...king hand-in-hand than by doctors and pharmacists ...cians work with pharmacists, medications are inten...ffectively," said Barry L. Carter, a professor in ...
(Date:11/23/2009)...nts up weaknesses of drug approval process in Unit...ov. 23 (HealthDay News) -- Problems with the popul...for heart attack, stroke and death, were known for... the market in 2004, a new report says. , Cont...., dangerous side effects were evident in 2000, a ...
Breaking Medicine News(10 mins):Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4
...t for vitamin D sufficiency, new, antimicrobial-s...hogens, and enhanced automated labor...r lead poisoning will also be on view, WASHINGTON...cal-diagnostics markets worldwide. The,Chelmsford,...
...ins some of the options available to people with d...s, including added benefits of Social Security Dis...eville, IL (PRWEB) July 29, 2008 –- Rising g... which represents people nationwide for http://ww...
...ealthcare of Atlanta Signs Multi-Year Agreement wi...m to All Employees , Burl...Inc, a leading provider of www.purewellness.com ...care systems and a not-for-profit organization tha...
...ported a breakthrough test on its mesothelioma blo...a cancer. Up to this point, the number one reason ...due to the fact that it is often misdiagnosed. , ...ma blog readers of a new scientific test that may ...
...fers Early Access to Research From 3000 Journals, ...ion database of,peer-reviewed literature, today an...), abstracts of accepted research papers published... BioMed Central and IEEE will also be available. S...
...of your neighborhood may influence your risk of ob...y of Utah. , The study, to be published i...Preventive Medicine , linked the body mass index (...eight if they lived in walkable neighborhoodsthose...
Other Medicine News:Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 2Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 3Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 4Health News:Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo 5Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 2Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 3Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 4Health News:People with Disabilities Seek Ways to Manage Higher Healthcare Costs 5Health News:Nationally Recognized Pediatric Healthcare System Chooses PureWellness for Employee Wellness Program 2Health News:Nationally Recognized Pediatric Healthcare System Chooses PureWellness for Employee Wellness Program 3Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 2Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 3Health News:LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients 4Health News:Scopus Adds Pre-Print Research Abstracts From Four Prestigious Publishers 2Health News:Scopus Adds Pre-Print Research Abstracts From Four Prestigious Publishers 3Health News:This old healthy house 2
...ion and tibial insert which provides a specially d...lexion to induce a smooth stable femoral roll-back...ral component comes in a PS open box design with p...ert in conjunction with the femur is designed to m...
Foundation® Knee CR System
...o provide the surgeon with surgical solutions for ...inically successful P.F.C. Total Knee System intro... innovation based on clinical proof.,P.F.C. SIGMA...izing femoro-tibial contact area, minimizing peak ...
BioPro® Uni Knee, Total Resurfacing Preserves Bone Stock
Medicine Products: